Ortho-McNeil, Inc., describe recent developments

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Ortho-McNeil, Inc.

Report 1: Ortho-McNeil, Inc. announced that it settled its patent litigation against Par Pharmaceutical Companies, Inc. and its subsidiaries, Par Pharmaceutical, Inc., and Kali Laboratories, Inc., generic drug manufacturers, regarding their infringement of the Ortho-McNeil patent for ULTRACET(R) (tramadol/acetaminophen).

As part of the settlement, Par/Kali acknowledged that the reissue patent for ULTRACET(R) is valid and enforceable, and that they infringed it by...

Want to see the full article?

• Purchase this article for only $3.00